Acorn Cardiovascular Release: Novel Implanted Heart Device Designed To Treat Effects Of Heart Failure To Be Considered By Medical Device Dispute Panel

WHAT: The Food and Drug Administration (FDA) will convene a Medical Device Dispute Resolution Panel (MDDRP) on Dec. 15 to consider the first device to specifically treat enlarged hearts and potentially reduce heart failure progression.